These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
344 related items for PubMed ID: 37418329
1. Drugs for inflammatory bowel disease. Med Lett Drugs Ther; 2023 Jul 10; 65(1680):105-112. PubMed ID: 37418329 [No Abstract] [Full Text] [Related]
2. Expanded table: Some drugs for inflammatory bowel disease. Med Lett Drugs Ther; 2023 Jul 10; 65(1680):e115-e119. PubMed ID: 37418332 [No Abstract] [Full Text] [Related]
3. Comparison table: some drugs for inflammatory bowel disease. Med Lett Drugs Ther; 2018 Jul 02; 60(1550):e117-e122. PubMed ID: 30036356 [No Abstract] [Full Text] [Related]
4. Drugs for inflammatory bowel disease. Med Lett Drugs Ther; 2018 Jul 02; 60(1550):107-114. PubMed ID: 30036352 [No Abstract] [Full Text] [Related]
7. Mirikizumab (Omvoh) for ulcerative colitis. Med Lett Drugs Ther; 2024 Mar 18; 66(1698):46-47. PubMed ID: 38466213 [No Abstract] [Full Text] [Related]
8. Table: Some drug interactions with drugs for IBD. Med Lett Drugs Ther; 2023 Jul 10; 65(1680):e114. PubMed ID: 37418331 [No Abstract] [Full Text] [Related]
9. Risankizumab (Skyrizi) - An IL-23 antagonist for Crohn's disease. Med Lett Drugs Ther; 2022 Dec 26; 64(1666):153-157. PubMed ID: 36542348 [No Abstract] [Full Text] [Related]
10. Etrasimod (Velsipity) for ulcerative colitis. Med Lett Drugs Ther; 2023 Nov 27; 65(1690):187-189. PubMed ID: 37983118 [No Abstract] [Full Text] [Related]
13. Role of biologics and biosimilars in inflammatory bowel disease: current trends and future perspectives. Rawla P, Sunkara T, Raj JP. J Inflamm Res; 2018 Nov 27; 11():215-226. PubMed ID: 29844695 [Abstract] [Full Text] [Related]